SCHEMBL6895665

SCHEMBL6895665

[CH2]Cc1ccc(-n2c(CC)nc3c(C)c(C#N)c(C)cc32)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.34
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
KMT2A Q03164 3/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
PTGER4 P35408 1/20 0.33
TSHR P16473 3/20 0.32
CASP1 P29466 2/20 0.32
CASP7 P55210 2/20 0.32
USP14 P54578 1/20 0.32
HSD17B10 Q99714 1/20 0.32
RAB9A P51151 2/20 0.32
MAPT P10636 2/20 0.32
NPC1 O15118 1/20 0.32
MDM2 Q00987 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RECQL P46063 1/20 0.32
GRM5 P41594 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1627487 0.86 PTGER4 (0.36) LMNAKDM4EALDH1A1KMT2APOLB
SCHEMBL1625943 0.86 PTGER4 (0.38) LMNAKDM4EALDH1A1KMT2APOLB
SCHEMBL1625557 0.86 PTGER4 (0.36) LMNAKDM4EALDH1A1KMT2APOLB
SCHEMBL27582799 0.83 PTGER4 (0.36) LMNAKDM4EALDH1A1KMT2APOLB
SCHEMBL27618372 0.83 HPGD (0.46) KDM4EALDH1A1KMT2AGAATSHR
SCHEMBL7192338 0.81 RXRA (0.47) KMT2APTGER4USP14HSD17B10SMN1; SMN2
SCHEMBL1625661 0.80 USP14 (0.41) LMNAKDM4EALDH1A1KMT2APOLB
SCHEMBL3946713 0.75 PTGER4 (0.52) KMT2APTGER4GRM5GRM1MEN1
SCHEMBL1625545 0.74 PTGER4 (0.47) LMNAALDH1A1POLBPTGER4TSHR
SCHEMBL1625193 0.73 PTGER4 (0.71) LMNAALDH1A1KMT2APTGER4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710054-B2 CONTAINING SULFONYLAMINOCARBONYL GROUPS; PROSTAGLANDIN INHIBITORS PFIZER INC 2004-03-23 US disclosed
US-20020107273-A1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents ASKAT INC. (JP) 2002-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107273-A1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents PTGS1, PTGS2, OPRM1 LMNA 3018/4885KDM4E 3701/4885ALDH1A1 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.